Tell your provider if you have kidney disease, low potassium, or a history of blood disorders so they can monitor you closely
The peptide is unaffected dilution changes the volume per dose, not the compound
There are quality and safety concerns around compounded or otherwise unregulated products, including immunogenicity and impurities depending on route and manufacturing quality
A peer-reviewed study in the Journal of Clinical Endocrinology and Metabolism confirming that CJC-1295 produces dose-dependent increases in growth hormone and IGF-1 levels sustained over multiple days with a well-characterized safety profile in healthy adults
BPC-157 is a multi-pathway angiogenic and growth-factor-receptor modulator with the deepest preclinical evidence in gastrointestinal protection, tendon repair, and emerging neurological models
The driver may be mast-cell-mediated or systemic rather than NF-B-local, so dose escalation will not reach it see the mast-cell note under Phenotype Considerations